Dr. Ollila is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
593 Eddy St
Providence, RI 02903
Summary
- Thomas Ollila, MD is an Oncologist specializing in Hematologic Oncology based in Providence, RI. He completed his medical education at Drexel University College of Medicine in 2012 and had his residency in Internal Medicine at Brown University the same year. He has numerous publications in reputable journals such as Blood Advances, British Journal of Haematology, and Frontiers in Oncology. His research topics have covered areas such as CAR-T therapy, follicular lymphoma, and primary central nervous system lymphoma.
Education & Training
- Brown UniversityResidency, Internal Medicine, 2012
- Drexel University College of MedicineClass of 2012
Certifications & Licensure
- RI State Medical License 2012 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis.Charles J Milrod, Kang Woo Kim, Christina Raker, Thomas A Ollila, Adam J Olszewski
British Journal of Haematology. 2024-06-01 - 3 citationsSubsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason Romancik, Pamela Allen
Blood Advances. 2024-05-28 - 4 citationsImpact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy.Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason Romancik
Blood Advances. 2024-05-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: